NUCLEOLIN and prostate carcinoma: Studying NCL in malignant tumors began in the 1980s and its high expression was identified in different cancers such as liver cancer, prostate cancer, renal cell carcinoma, lung cancer, and colon cancer.20, 21, 22, 23, 24, 25